Efficacy and Safety of Intravenous Bisphosphonates in Patients with Bone Metastases Caused by Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Efficacy and Safety of Intravenous Bisphosphonates in Patients with Bone Metastases Caused by Metastatic Breast Cancer

Published:2007-07 Issue: Volume:7 Page:S14-S20
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Lipton Allan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Events per person year–a dubious concept;Windeler;BMJ,1995

2. Oral clodronate in breast cancer patients with bone metastases: a randomized study;Kristensen;J Intern Med,1999

3. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases];Tubiana-Hulin;Bull Cancer,2001

4. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group;Hortobagyi;N Engl J Med,1996

5. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-199a-3p suppresses neuroinflammation by directly targeting MyD88 in a mouse model of bone cancer pain;Life Sciences;2023-11

2. Neurologic Complications of Cancer;Holland‐Frei Cancer Medicine;2022-10-21

3. Cardiovascular Safety of Denosumab Across Multiple Indications: A Systematic Review and Meta‐Analysis of Randomized Trials;Journal of Bone and Mineral Research;2020-09-19

4. Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology;The Journal of Clinical Endocrinology & Metabolism;2020-02-19

5. Relative Chemo-, Hormonal, and Immunosensitivity;Metastatic Spine Disease;2018